PP405, a topical LDH inhibitor, has shown to stimulate hairfolliclestemcellproliferation in humans with moderate hair loss. They are advancing to more detailed trials this year.
Exosome hair therapy involves injecting stemcell-derived exosomes into the scalp to boost hairfollicle regeneration and repair. Exosomes, which are not stem cells but products of them, contain bioactive chemicals and specific growth factors that promote new blood vessel formation, increase cellproliferation, reduce inflammation, and improve tissue repair, all crucial for hair health.
NMN shows promise in promoting hair growth by reducing oxidative stress and weakening androgens. It may be a beneficial addition to hair loss treatments like Minoxidil and Finasteride.
Microneedling with needle lengths of 1.5mm to 2.5mm to stimulate hairfolliclestem cells for potential hair growth. Using needles longer than 2.5mm is not recommended due to risk of puncturing veins in the scalp. A dermastamp is suggested over a roller.
PP405 is a new hair loss treatment in phase 2 trials that may promote hair growth by increasing lactate production and activating hairfolliclestem cells. It could potentially replace hormone-disrupting treatments like Minoxidil and finasteride.